Omada Expands Platform with Cholesterol Management to Tackle Cardiovascular Risk

Event summary

  • Omada Health added cholesterol management to its integrated platform on February 19, 2026, complementing existing support for weight, glucose, blood pressure, and GLP-1 therapy.
  • The launch follows data showing only 41% of U.S. adults with atherosclerotic cardiovascular disease reach healthy LDL-C levels.
  • Omada for Cholesterol integrates human-led coaching with AI to address cholesterol as part of the broader cardiometabolic system.
  • The expansion was developed in response to demand from a market-leading employer customer.

The big picture

Omada's expansion into cholesterol management reflects the growing demand for comprehensive, between-visit care for chronic conditions. The move aligns with broader industry trends toward integrated cardiometabolic care, as traditional healthcare models struggle to sustain long-term behavior change. With over one million members served, Omada is positioning itself as a one-stop partner for employers and health plans seeking to manage cardiovascular risk holistically.

What we're watching

Integration Success
Whether Omada can effectively integrate cholesterol management with its existing cardiometabolic support services without diluting focus.
Employer Adoption
The pace at which other large employers adopt the cholesterol management feature, given the initial launch with a market-leading employer.
Outcome Metrics
How quickly Omada can demonstrate measurable improvements in LDL-C levels and cardiovascular risk reduction among its members.